Concepedia

Christopher Aquino

CA

Statistics

Publications

13

Citations

1K

H-Index

13

Active since

1996

Affiliations

GlaxoSmithKline (United States)(Current)

Research Triangle Park Foundation

Christopher Aquino is an author at GlaxoSmithKline (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1996–2019

13

Publications

13

Flavonoids Suppress Pseudomonas aeruginosa Virulence through Allosteric Inhibition of Quorum-sensing Receptors

Jon E. Paczkowski, Sampriti Mukherjee, Amelia R. McCready et al. · Journal of Biological Chemistry · 2017 · 315 citations · Full text

, , +16

Defects in keratinocyte activation during wound healing in the syndecan-1-deficient mouse

Mary Ann Stepp, Heather E. Gibson, Purvi H. Gala et al. · Journal of Cell Science · 2002 · 231 citations

, , +17

Discovery of 1,5-Benzodiazepines with Peripheral Cholecystokinin (CCK-A) Receptor Agonist Activity. 1. Optimization of the Agonist “Trigger”

Christopher Aquino, Duncan Armour, Judd Berman et al. · Journal of Medicinal Chemistry · 1996 · 101 citations · Full text

, , +14

Optimization of 3-(1<i>H</i>-Indazol-3-ylmethyl)-1,5-benzodiazepines as Potent, Orally Active CCK-A Agonists

Brad R. Henke, Christopher Aquino, Larry S. Birkemo et al. · Journal of Medicinal Chemistry · 1997 · 86 citations · Full text

, , +13

Discovery of a Highly Potent, Nonabsorbable Apical Sodium-Dependent Bile Acid Transporter Inhibitor (GSK2330672) for Treatment of Type 2 Diabetes

Yulin Wu, Christopher Aquino, David J. Cowan et al. · Journal of Medicinal Chemistry · 2013 · 79 citations · Full text

, , +13

1–5 of 13